DGX Logo

Quest Diagnostics Inc (DGX) Stock Forecast & Price Prediction

Live DGX Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Diagnostics & Research

$165.19

+2.55 (1.57%)

12 Month Price Forecast For DGX

$165.19
Current Price
$18.27B
Market Cap
18 Ratings
Buy 9
Hold 9
Sell 0
Wall St Analyst Ratings

Distance to DGX Price Forecasts

+15.0%
To High Target of $190.00
+8.4%
To Median Target of $179.00
-6.6%
To Low Target of $154.36

DGX Price Momentum

+1.1%
1 Week Change
+8.8%
1 Month Change
+30.3%
1 Year Change
+9.5%
Year-to-Date Change
-1.1%
From 52W High of $167.08
+34.0%
From 52W Low of $123.30

๐Ÿค” Considering Quest Diagnostics (DGX)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 11, 2025 6:25 AM UTC

DGX Analyst Ratings & Price Targets

Based on our analysis of 30 Wall Street analysts, DGX has a neutral consensus with a median price target of $179.00 (ranging from $154.36 to $190.00). The overall analyst rating is Buy (7.9/10). Currently trading at $165.19, the median forecast implies a 8.4% upside. This outlook is supported by 9 Buy, 9 Hold, and 0 Sell ratings.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

DGX Analyst Consensus

9
Buy
9
Hold
0
Sell

DGX Price Target Range

Low
$154.36
Average
$179.00
High
$190.00
Current: $165.19

Latest DGX Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for DGX.

Date Firm Analyst Rating Change Price Target
Feb 4, 2025 JP Morgan Lisa Gill Neutral Maintains $180.00
Feb 3, 2025 UBS Kevin Caliendo Neutral Maintains $170.00
Feb 3, 2025 Mizuho Ann Hynes Outperform Maintains $178.00
Feb 3, 2025 Piper Sandler David Westenberg Neutral Reiterates $180.00
Jan 31, 2025 Barclays Stephanie Davis Equal-Weight Maintains $175.00
Jan 31, 2025 Truist Securities David Macdonald Hold Maintains $182.00
Jan 6, 2025 Leerink Partners Michael Cherny Outperform Upgrade $174.00
Dec 17, 2024 Morgan Stanley Erin Wright Overweight Upgrade $172.00
Dec 13, 2024 B of A Securities Derik De Bruin Buy Maintains $182.00
Dec 10, 2024 Jefferies Tycho Peterson Buy Assumes $185.00
Oct 28, 2024 Piper Sandler David Westenberg Neutral Maintains $165.00
Oct 24, 2024 Mizuho Ann Hynes Outperform Maintains $174.00
Oct 23, 2024 Citigroup Patrick Donnelly Buy Maintains $185.00
Oct 23, 2024 Baird Eric Coldwell Outperform Upgrade $182.00
Oct 23, 2024 UBS Kevin Caliendo Neutral Maintains $166.00
Oct 23, 2024 Barclays Stephanie Davis Equal-Weight Maintains $168.00
Oct 7, 2024 Truist Securities David Macdonald Hold Maintains $165.00
Aug 28, 2024 Evercore ISI Group Elizabeth Anderson In-Line Reinstates $165.00
Aug 27, 2024 Barclays Stephanie Davis Equal-Weight Maintains $154.00
Jul 29, 2024 Piper Sandler David Westenberg Neutral Maintains $150.00

Stocks Similar to Quest Diagnostics Inc

The following stocks are similar to Quest Diagnostics based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Quest Diagnostics Inc (DGX) Financial Data

Quest Diagnostics Inc has a market capitalization of $18.27B with a P/E ratio of 21.5x. The company generates $9.54B in trailing twelve-month revenue with a 8.8% profit margin.

Revenue growth is +8.4% quarter-over-quarter, while maintaining an operating margin of +14.2% and return on equity of +13.2%.

Valuation Metrics

Market Cap $18.27B
Enterprise Value $23.67B
P/E Ratio 21.5x
PEG Ratio 16.9x
Price/Sales 1.9x

Growth & Margins

Revenue Growth (YoY) +8.4%
Gross Margin +32.6%
Operating Margin +14.2%
Net Margin +8.8%
EPS Growth +0.4%

Financial Health

Cash/Price Ratio +4.1%
Current Ratio 1.3x
Debt/Equity 100.7x
ROE +13.2%
ROA +5.7%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) Company Overview

About Quest Diagnostics Inc

What They Do

Provides diagnostic testing and services globally.

Business Model

The company generates revenue by offering a wide range of diagnostic testing services, including routine and advanced clinical testing, to various stakeholders such as healthcare providers, insurers, and patients. By utilizing a network of laboratories and service centers, it ensures accessibility and efficiency in delivering its services.

Additional Information

Founded in 1967 and headquartered in Secaucus, New Jersey, Quest Diagnostics operates under multiple brands and also offers information technology solutions for healthcare organizations. Its diversified service offerings position it well within the healthcare industry, catering to a broad spectrum of clients including hospitals, employers, and pharmaceutical companies.

Company Information

Sector

Healthcare

Industry

Diagnostics & Research

Employees

50,000

CEO

Mr. James E. Davis

Country

United States

IPO Year

1996

Quest Diagnostics Inc (DGX) Latest News & Analysis

DGX stock latest news image
Quick Summary

DGX reports strong growth in Q4 2024, driven by high demand for blood tests assessing Alzheimer's disease risk, indicating a positive trend in brain health products.

Why It Matters

Strong demand for Alzheimer's blood tests indicates growing market potential for DGX, potentially boosting revenue and attracting investor interest in the healthcare sector.

Source: Zacks Investment Research
Market Sentiment: Positive
DGX stock latest news image
Quick Summary

Zacks Style Scores can guide investors in selecting strong, market-beating stocks for their portfolios.

Why It Matters

The Zacks Style Scores can help identify high-potential stocks, offering investors a strategy to enhance portfolio performance and capitalize on market opportunities.

Source: Zacks Investment Research
Market Sentiment: Positive
DGX stock latest news image
Quick Summary

Zacks Style Scores can assist investors in selecting strong, market-beating stocks for their portfolios.

Why It Matters

The Zacks Style Scores can guide investors in selecting high-potential stocks, potentially enhancing portfolio performance and improving returns in a competitive market.

Source: Zacks Investment Research
Market Sentiment: Positive
DGX stock latest news image
Quick Summary

Zacks Style Scores can assist investors in selecting strong, market-beating stocks for their portfolios.

Why It Matters

The Zacks Style Scores can guide investors in selecting stocks with potential for higher returns, enhancing portfolio performance amidst market volatility.

Source: Zacks Investment Research
Market Sentiment: Positive
DGX stock latest news image
Quick Summary

Quest Diagnostics reported Q4 results with adjusted EPS of $2.23, exceeding analyst expectations of $2.18.

Why It Matters

Quest Diagnostics' strong Q4 results and EPS exceeding expectations indicate financial health and growth potential, likely boosting investor confidence and stock performance.

Source: The Motley Fool
Market Sentiment: Positive
DGX stock latest news image
Quick Summary

Quest Diagnostics (DGX) shares rose over 5% on Thursday, approaching an all-time high, outperforming the S&P 500, which gained 0.8% that day.

Why It Matters

Quest Diagnostics' stock nearing an all-time high signals strong investor confidence and outperformance against the broader market, indicating potential growth and stability in the healthcare sector.

Source: The Motley Fool
Market Sentiment: Positive

Frequently Asked Questions About DGX Stock

What is Quest Diagnostics Inc's (DGX) stock forecast for 2025?

Based on our analysis of 30 Wall Street analysts, Quest Diagnostics Inc (DGX) has a median price target of $179.00. The highest price target is $190.00 and the lowest is $154.36.

Is DGX stock a good investment in 2025?

According to current analyst ratings, DGX has 9 Buy ratings, 9 Hold ratings, and 0 Sell ratings. The stock is currently trading at $165.19. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for DGX stock?

Wall Street analysts predict DGX stock could reach $179.00 in the next 12 months. This represents a 8.4% increase from the current price of $165.19. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Quest Diagnostics Inc's business model?

The company generates revenue by offering a wide range of diagnostic testing services, including routine and advanced clinical testing, to various stakeholders such as healthcare providers, insurers, and patients. By utilizing a network of laboratories and service centers, it ensures accessibility and efficiency in delivering its services.

What is the highest forecasted price for DGX Quest Diagnostics Inc?

The highest price target for DGX is $190.00 from at , which represents a 15.0% increase from the current price of $165.19.

What is the lowest forecasted price for DGX Quest Diagnostics Inc?

The lowest price target for DGX is $154.36 from at , which represents a -6.6% decrease from the current price of $165.19.

What is the overall DGX consensus from analysts for Quest Diagnostics Inc?

The overall analyst consensus for DGX is neutral. Out of 30 Wall Street analysts, 9 rate it as Buy, 9 as Hold, and 0 as Sell, with a median price target of $179.00.

How accurate are DGX stock price projections?

Stock price projections, including those for Quest Diagnostics Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.